NDMA Is Present In Hot Dogs, Bacon And Other Cured Meats In High Amounts

Cancer lawsuits against generic ranitidine manufacturers have been dismissed as the science behind NDMA cancer is studied

Thursday, July 22, 2021 - A comment on an article written in MedPage Today sparked interest in finding out just how big or small a nanogram is. Zantac NDMA cancer science is measured in nanograms, and the Food and Drug Administration has set the safe NDMA Zantac limit at 96 nanograms. The commenter sought to put into perspective the fact that the American diet typically consists of anywhere between four and eight grams of what the FDA considers to be a likely carcinogenic substance, and that a youngster's peanut butter sandwich is more carcinogenic than a Zantac tablet. The commenter wrote, "How many tablets of ranitidine are required to equal the NDMA in one beef hotdog? Or two strips of cooked bacon? Dr. Bruce Ames noted in a Science review about 20 years ago that the American diet contains 4-8 grams of carcinogenic or suspected carcinogenic chemicals every day. Why worry about a few nanograms of NDMA in a hotdog while you are frizzling it over coals on the grill? Probably the largest single source of carcinogens in a child's diet is peanut butter, especially if you eat organic. The numbers need to be put into perspective." The ranitidine molecule becomes unstable allegedly due to high heat and degrades to become N-nitrosodimethylamine (NDMA), a deadly carcinogen. One nanogram of ranitidine is about 1, one billionth of a gram. If a ranitidine tablet contained 100 nanograms, it would take ten million doses to equal one gram of NDMA.

Colorectal cancer, breast cancer, prostate cancer, pancreatic cancer, and others are linked to years of consuming red, processed meat, ironically, the foods that cause heartburn and prompt one to reach for a Zantac in the first place. More than seventy thousand individuals have registered their intent to file a lawsuit with Zantac cancer lawyers against French drug manufacturer Sanofi, accusing them of failing to warn the public of their knowledge that ranitidine becoming carcinogenic under certain conditions. Other ranitidine lawsuits have been dismissed. An entire class of Zantac ranitidine lawsuits was set aside recently by US District Court Judge Robin Rosenberg, presiding over ranitidine multidistrict litigation (MDL) who ruled that manufacturers of generic ranitidine, and the retailers who sold it, can not be held responsible for failing to warn consumers that it causes cancer. At the core of the decision is that generic versions of a drug can not be relabeled or redesigned and must be kept the same as the original brand. Generic manufacturers can not be accused of failing to warn consumers since to do so would have violated federal law which preempts state law. According to EndPoint News, "State law would require them to redesign or re-label ranitidine products, which they could not do under their federal duty of sameness,"a court document read. "They were not required to stop selling the products to comply with both federal and state law. Thus, the failure-to-warn and negligence claims are pre-empted."

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.